TRESIBA PENFILL
INSULINE DEGLUDEC
Active substance
INSULINE DEGLUDEC
Laboratory
LAPROPHAN
What is this medicine?
TRESIBA PENFILL: This substance is used in diabetes management. It acts on blood glucose through a mechanism that depends on the active ingredient.
Verified summary
INSULINE DEGLUDEC, SOLUTION INJECTABLE, 100 UI / ML, BOITE DE 5 CARTOUCHES
Common uses
Common uses: type 2 diabetes or insulin needs, metabolic follow-up, and blood-glucose control according to patient profile. General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
Diabetology - antidiabetic
Laboratory
LAPROPHAN
Strength
100 UI / ML
Form
SOLUTION INJECTABLE
Presentation
BOITE DE 5 CARTOUCHES
Commercial status
Non commercialisé / Sans Prix
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: Not available in the verified source
Medicines with the same active substance
TRESIBA FlexTouch 100 U/ml
100 U/ml · Boite de 1 stylos pré remlpi de 3 ML
243,00 MAD
TRESIBA FlexTouch 100 U/ml
100 U/ml · Boite de 5 stylos pré remlpi de 3 ML
1.040,00 MAD
TRESIBA FLEXTOUCH
200 UI / ML · BOITE DE 1
Not available in the verified source
TRESIBA FLEXTOUCH
200 UI / ML · BOITE DE 3
Not available in the verified source